
You can purchase shares of Insight Molecular (NASDAQ:IMDX) through any online brokerage.
Other companies in Insight Molecular’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Insight Molecular has a consensus price target of $9.67.
The stock price for Insight Molecular (NASDAQ: IMDX) is $2.96 last updated October 30, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Insight Molecular.
Insight Molecular does not have any upcoming earnings scheduled.
There is no upcoming split for Insight Molecular.
Insight Molecular is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular...